Advertisement

Topics

Catabasis Pharmaceuticals to Present Results from the MoveDMD® Trial of Edasalonexent ...

03:06 EDT 23 Jun 2017 | BioMedReports - Blog

Investor and Media Contact
Catabasis Pharmaceuticals, Inc.
Andrea Matthews, 617-349-1971
amatthews@catabasis.com

Read more...

Original Article: Catabasis Pharmaceuticals to Present Results from the MoveDMD® Trial of Edasalonexent ...

NEXT ARTICLE

More From BioPortfolio on "Catabasis Pharmaceuticals to Present Results from the MoveDMD® Trial of Edasalonexent ..."

Advertisement
Quick Search
Advertisement
Advertisement